JALYSSA VALENCIA: Open Payments
NPI 1851068407 · WAGONER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 14 payments from 8 companies in 2025. Trend: 2023 $25 · 2024 $132 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $194 |
| PROTEGA PHARMACEUTIALS INC | 3 | $47 |
| Valinor Pharma, LLC | 2 | $35 |
| Astellas Pharma US Inc | 1 | $26 |
| Averitas Pharma Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: SPRAVATO, ROXYBOND, MOVANTIK, Veozah, QUTENZA, Qelbree, JOURNAVX, MOUNJARO.
Industry payments across OK — which companies pay providers there.
